Disease
Acute Lymphoblastic Leukemia, ALL
Do you plan to organise a webinar?
Why not use the CMN platform and get exposed to the global gene editing community
+20k readers/month | +13k followers | Top-1 CRISPR News Site | sales@crisprmedicinenews.com
Read more here
Diseases
Overview diseases where gene editing tools like CRISPR, Prime Editors, Base Editors, ZFNs, TALENs, CAS-CLOVER, MegaTAL and MegaNucleases are applied.
Stay updated about diseases and trials in gene editing field - Sign up to the free weekly CMN Newsletter here.
Trials
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
Sickle Cell Disease, SCD, and Transfusion Dependent Beta-Thalassaemia, TDT, (NCT04208529)
Sponsors:
Vertex Pharmaceuticals Incorporated
Sponsors:
Vertex Pharmaceuticals Incorporated
IND Enabling
Phase I
Phase II
Phase III
T-cell Acute Lymphoid Leukaemia, ALL, (NCT05397184)
Sponsors:
Great Ormond Street Hospital for Children NHS Foundation Trust
Sponsors:
Great Ormond Street Hospital for Children NHS Foundation Trust
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
